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Abstract 
Multiple Sclerosis (MS) is the most prevalent neurological disorder affecting 
younger adults. A symptom affecting the majority of people with MS (pwMS), and 
which can significantly impede the person’s ability to engage in everyday activities, 
is fatigue. This study aimed to further current understandings of the little understood 
concept of cognitive fatigue in pwMS. Cognitive fatigue was examined through 
objective and subjective (intellectual and online) measures. Participants included 31 
pwMS (M = 47.77, SD = 12.19) and 30 healthy controls (M = 44.37, SD = 11.37), 
who completed neuropsychological assessments, including a task of sustained 
attention administered twice during testing. Participants completed a single 
intellectual assessment of cognitive fatigue, and online assessments of cognitive 
fatigue repeated three times throughout testing. The findings indicated that fatigue in 
MS is experienced temporally, with higher self-reports of fatigue following sustained 
mental effort. The online measures were the strongest predictor of actual test 
performance. Further, pwMS overestimated their levels of fatigue relative to actual 
test performance indicating possible reduced levels of insight into actual declining 
abilities. The results highlight the need for clinicians to utilise various measures 
when examining the multifaceted phenomenon of cognitive fatigue, and address 
perceptions pwMS may have about their fatigue. 
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 Examining Cognitive Fatigue in Multiple Sclerosis: Can Self-Reported Fatigue 
Predict Deteriorating Test Performance? 
Multiple sclerosis (MS) is the most prevalent neurological disorder affecting younger 
adults in the developed world (Palmer, 2011). Whilst the symptoms and progression 
of MS are highly heterogeneous, arguably its most pervasive and debilitating 
symptom, experienced in up to 87% of people with MS (pwMS), is fatigue (Krupp, 
LaRocca, Muir-Nash, & Steinberg, 1989). Fatigue is defined as a subjective lack of 
physical and/or mental energy that interferes with usual or desired activities, social 
behaviour and psychological wellbeing (DeLuca, 2005). Importantly, fatigue can 
considerably impact everyday functioning, even in the early stages of the disease 
(Benedict et al., 2002; Simmons, Tribe, & McDonald, 2010). However, despite its 
significance, the experience of cognitive fatigue still remains poorly understood and 
defined (Genova et al., 2013). Developing an increased understanding of the nature 
of cognitive fatigue in MS is vital, not only to improve the assessment and diagnostic 
proficiencies of clinicians working with MS patients, but also for the provision of 
more effective remediation and compensation strategies which aim to improve the 
quality of life. 
MS Characteristics  
 MS is a chronic progressive autoimmune disease of the central nervous 
system (CNS), characterised by inflammatory demyelination of both grey and white 
matter (Genova et al., 2013; Harbo, Gold, & Tintoré, 2013; Trapp & Nave, 2008). 
Demyelination occurs as a result of the destruction of myelin sheaths and 
oligodendrocytes (myelin-producing cells), which causes scar-like lesions. These 
lesions, sclerotic plaques, can distort or block transmission of neural impulses 
(Bitsch, Schuchardt, Bunkowski, Kuhlmann, & Brück, 2000; Bjartmar & Trapp, 
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2003; Trapp et al., 1998). The accumulation of sclerotic plaques, and eventual axonal 
and neuronal degeneration, can lead to permanent impairment of movement, 
sensations, and cognition (Bjartmar & Trapp, 2001). Lesions can occur in any 
location throughout the CNS, commonly affected areas include the spinal cord, 
subcortical white matter and the cortex (Brassington & Marsh, 1998). As a result of 
varying anatomical locations that can be impacted, the symptoms and trajectory of 
the disease also vary, making MS highly heterogeneous (Brassington & Marsh, 1998; 
Lee, Taghian, & Petratos, 2014).  
 The most common types of MS are: relapsing-remitting (RRMS), secondary-
progressive (SPMS) and primary-progressive (PPMS; Lublin & Reingold, 1996; see 
Figure 1). Other classifications include: progressive-relapsing (PRMS), benign and 
cortical MS. RRMS affects 80 percent of pwMS and is typically seen in the initial 
stages (Noseworthy, Lucchinetti, Rodriguez, & Weinshenker, 2000). The average 
age of RRMS diagnosis is 30 years, and it is three times more prevalent in females 
(Miller & Leary, 2007). RRMS is characterised by periods of disease relapse, 
significant worsening of neurological symptoms over several days, followed by 
disease remission (symptomatic improvement). Relapses are assumed to be a direct 
result of active inflammatory lesions, and accompanying myelin loss, which slows or 
blocks neural transmissions (Centonze et al., 2010). A relapse is defined as the 
occurrence, recurrence or worsening of symptoms that lasts over 48-hours. These 
symptoms must not be associated with fever, and occur at least 30-days after 
improvement/stability (Schumacher et al., 1965). Remission occur as a result of 
inflammation resolution, where the sodium (Na+) channels along demyelinated 
axons, and re-myelination of affected nerves, are reorganised (see Figure 2; Trapp & 
Nave, 2008). Remission occurs spontaneously, or in response to corticosteroid 
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medication. 
 Following a period of 10 to 15 years, approximately half of individuals with 
RRMS develop SPMS (Trapp et al., 1998). Relapses are less apparent due to 
continually worsening symptoms. Periods of spontaneous remission are no longer 
experienced and corticosteroid medications become ineffective, resulting in eventual 
axonal destruction (see Figure 3). This is the result of amyloid precursor protein 
accumulation in the nerve, resulting in permanent deficits (Trapp, Ransohoff, Fisher, 
& Rudick, 1999). 
 PPMS, a common sub-type of MS, affects approximately 15 percent of 
pwMS. Unlike RRMS, prevalence of PPMS is equal amongst both sexes, and age of 
diagnosis is approximately 40 (Miller & Leary, 2007). PPMS is characterised by 
continual worsening of symptoms without defined relapses or remissions (Lublin & 
Reingold, 1996; Miller & Leary, 2007). 
 As previously mentioned, the symptoms of MS are highly variable and 
thought to be dependent on the locations where lesions develop (Goverover, Genova, 
Griswold, Chiaravalloti, & DeLuca, 2014). Traditionally MS has been viewed as a 
disease where the neurological deficits result exclusively in physical impairments. 
Symptoms commonly experienced by pwMS includes weakness, tremors, tingling, 
numbness, paralysis, vertigo, pain, and physical fatigue all resulting in reduced 
mobility. PwMS may also suffer from bladder and bowel disturbances, vision and 
other sensory impairments, and sexual dysfunction (Thompson, 2001). 
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Figure 1. Clinical courses of MS. Adapted from “Defining the clinical course of 
multiple sclerosis: results of an international survey. National Multiple Sclerosis 
Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple 
Sclerosis” by F. D., Lublin, and S. C. Reingold, 1996, Neurology, 46, p. 909. 
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Figure 2. The pathogenic process of demyelination and remyelination in MS. (A) 
Normal myelinated fibers; (B) demyelination by inflammatory processes which 
causes conduction blockages; (C) Na+ channel redistribution; (D) re-myelination. 
Both C & D restores and contributes to clinical remission. From “Neurodegeneration 
in Multiple Sclerosis: Relationship to Neurological Disability”, by B. D. Trapp, R. 
M. Ransohoff, E. Fisher, and R. A. Rudick, 1999, Neuroscientist, 5, 49. 
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Figure 3. Axonal transection during inflammatory demyelination. (A) Axonal 
transection which is a consistent feature of inflammatory demyelination lesions. This 
results in (B) degeneration of the distal axonal segment and (C) irreversible loss of 
neuronal function. From “Neurodegeneration in Multiple Sclerosis: Relationship to 
Neurological Disability”, by B. D. Trapp, R. M. Ransohoff, E. Fisher, and R. A. 
Rudick, 1999, Neuroscientist, 5, 50. 
  
 Over the previous two decades, there has been increasing research 
highlighting that in addition to physical symptoms, cognitive impairments are also 
highly prevalent in pwMS (Goverover et al., 2014). Cognitive impairments have 
been found to affect individuals at any stage throughout the disease and can occur 
independently from physical impairments (Benedict et al., 2002). It is reported that 
cognitive difficulties affect up to 65 percent of pwMS, which in turn can negatively 
affect quality of life through reduced social interactions, difficulty performing 
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household chores and withdrawal from work (Honan, Brown, & Batchelor, 2015; 
Rao, Leo, Bernardin, & Unverzagt, 1991). Benedict et al. (2006), interested in the 
domains affected in pwMS, developed and validated the Minimal Assessment of 
Cognitive Function in MS. Through a principle components analysis, they revealed 
three general domains of impairment: processing speed/working memory, memory, 
and executive function. These findings were supported by Chiaravalloti and DeLuca 
(2008).  
Cognitive fatigue 
 Cognitive fatigue, whilst largely viewed as a subjective experience, can be 
examined through objective and subjective measures (see Figure 4). Objectively, 
cognitive fatigue is believed to be examinable through deficits on standard 
neurological tests (Krupp & Elkins, 2000). However, the explanation as to why 
impairments occur as a result of fatigue is still under debate (Sandry, Genova, 
Dobryakova, DeLuca, & Wylie, 2014). One proposed explanation is that 
impairments are secondary to fatigue (Coyne et al., 2015). This is not to say all 
cognitive impairments are due to fatigue, but rather, it is likely that performance 
becomes undermined by fatigue. The effect of fatigue on performance has been 
examined in relation to physical symptoms, where it was found that 6-minutes of 
walking resulted in increased subjective reports of physical fatigue, as well as 
objective increases in postural sway and reduced lower limb strength in pwMS 
(McLoughlin, Barr, Crotty, Sturnieks, & Lord, 2014). These findings suggest that 
sustained physical effort results in impairments. However, the effect that sustained 
mental effort has on cognitive abilities remains poorly understood (Sandry et al., 
2014). This is despite research indicating that pwMS link their cognitive dysfunction 
to cognitive fatigue; known clinically as the “fatigue cascade effect” (Coyne et al., 
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2015). The inadequate examination of the relationship between the experience of 
cognitive fatigue and impairments may be due to the lack of consensus on methods 
for examining both subjective and objective cognitive fatigue (DeLuca, 2005).  
 Cognitive fatigue is typically assessed through self-report, both clinically and 
in prior research. Branas, Jordan, Fry-Smith, Burls, and Hyde (2000) report that there 
are two ‘types’ of fatigue that pwMS experience. There is the experience of an 
abnormal, constant and persistent sense of tiredness, as well as the experience of 
increased tiredness in direct response to undertaking specific tasks, or as the day 
progresses. These experiences have recently been, coined by Genova et al. (2013) as 
trait fatigue and state fatigue. Whereas trait fatigue is assessed using ‘intellectual’ 
self-report measures (i.e., over an extended period of time), state fatigue is assessed 
using ‘online’ self-report measures (i.e., the current point in time). The majority of 
research has focused on the experience of trait fatigue, with research into state 
fatigue being limited (Krupp & Elkins, 2000; Sandry et al., 2014).  
 To date, research has failed to find a relationship between objectively 
measured (neurological testing) and subjectively reported cognitive fatigue (Paul, 
Beatty, Schneider, Blanco, & Hames, 1998). However, this may be due to the 
techniques used to assess both objective and subjective cognitive fatigue.  Thus, the 
current paper more specifically attempts to clarify the relationship between 
subjective (trait and state) and objectively measured fatigue.
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Figure 4. Schematic overview of the methods available for assessing cognitive fatigue. The current study is assessing (A) Online awareness is 
the association between a subjective measure fatigue, an online assessment of (state fatigue) and the objective measure of declining performance 
over time (temporal hypothesis). The current study also examines (B) Intellectual awareness is the association between intellectual assessments 
of fatigue (trait fatigue) and declining performance over time.
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Subjective Measurement of Fatigue  
The ability to assess subjective measures of fatigue, whether cognitive or 
physical, is largely dependent on individual’s awareness into their cognitive or 
physical state. Self-awareness has traditionally been defined through a hierarchical 
pyramid model, with progression to higher levels dependant on successful attainment 
of preceding levels (Crosson et al., 1989). At the base of the pyramid is intellectual 
awareness, which refers to the general ability to show understanding of difficulties 
experienced. Individuals who possess advanced intellectual awareness have the 
ability to recognise the ramifications of their impairments. The second level is 
emergent awareness. This refers to the ability to recognise impairments as they occur 
and consequently engage in compensatory strategies. The most advanced level of 
self-awareness is anticipatory awareness, which refers to the ability, not only to be 
aware of impairment, but also to anticipate when problems will arise. 
 In contrast, Toglia and Kirk (2000) postulate that self-awareness is a dynamic 
process, consisting of metacognitive knowledge and online awareness. They argue 
that metacognitive knowledge (also referred to as ‘intellectual’ awareness) refers to 
an individual’s knowledge of task characteristics, and task requirements, as well as 
strategies stored in long-term memory to assist task completion. Online awareness, 
on the other hand, occurs throughout a task and involves monitoring and regulation 
of performance. This involves anticipatory awareness (monitoring task demands) as 
well as emergent awareness (awareness of performance). Having accurate 
assessments of online awareness (i.e., accurate self-monitoring) is beneficial to 
individuals, as this provides information regarding when to engage in compensatory 
strategies (e.g., when presented with a large quantity of information, an individual 
takes notes as they have awareness of memory difficulties).  
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 The majority of research examining self-awareness in pwMS has primarily 
sought to examine ‘intellectual’ awareness of cognitive abilities/impairments 
(Goverover, Chiaravalloti, Gaudino-Goering, Moore, & DeLuca, 2009). This is 
achieved through examining how ‘intellectual’ assessments of cognition (e.g., rating 
levels of cognitive difficulties experienced over the preceding four weeks) map onto 
‘actual’ cognitive difficulties, assessed through standardised neuropsychological 
assessments (Goverover et al., 2009; Sherman, Rapport, & Ryan, 2008). These 
studies demonstrated negligible relationships between self-reported difficulties and 
actual performance on cognitive tasks. 
Recent research, however, has examined both ‘intellectual’ and ‘online’ 
awareness of cognitive difficulties in pwMS. Specifically, Goverover et al. (2014) 
demonstrated that online, rather than intellectual assessment of cognitive 
performance was associated with actual performance. In this case, online awareness 
was inferred by the alignment between online reporting and actual task performance. 
Goverover et al. argued these results are likely to be due to intellectual measures 
reflecting individual’s self-efficacy beliefs, whereas online measures are based off 
both self-efficacy and continual monitoring of performance. Interestingly, their study 
found that levels of online awareness did not differ between pwMS and controls. 
However, intellectual awareness was lower for pwMS, perhaps highlighting that 
pwMS may struggle to accurately rate the difficulties, as they occur over time, 
potentially due to poor memory (Brassington & Marsh, 1998) or depressed mood 
(Lovera, Bagert, Smoot, & Wild 2006). Importantly, these findings highlight two 
imperative points. Firstly, online and intellectual measures of performance are 
discrepant constructs. Secondly, online assessments are more consistent with actual 
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performance; therefore, the use of online measures may offer a more sensitive and 
ecologically valid method of assessing insight into difficulties.  
The findings of Goverover et al. (2014) offer valuable information into other 
areas of self-awareness in pwMS. Specifically, many studies conducted into 
cognitive fatigue in pwMS, have found negligible relationships between objective 
and subjective measures of fatigue. However, these studies have typically relied on 
intellectual assessments (Morrow, Weinstock-Guttman, Munschauer, Hojnacki, & 
Benedict, 2009), which, if similar to intellectual awareness of cognitive abilities, may 
not accurately reflect cognitive fatigue. Through implementing both intellectual and 
online assessments, it may be possible to assess both intellectual and online 
awareness of cognitive fatigue. This can be achieved if self-report measures are 
compared to objective performance on cognitive tasks that are sensitive to the effects 
of fatigue (i.e., aligning self-report with objective measure). 
Trait fatigue.  
 Trait fatigue refers to self-reported fatigue as is subjectively experienced over 
a period of time (i.e., ‘intellectual’ self-reports; Genova et al., 2013). Trait fatigue is 
viewed as being relatively stable, meaning it is not likely to drastically change over 
time. The Fatigue Impact Scale (FIS) developed for and validated in pwMS assesses 
trait fatigue (Fisk, Pontefract, Ritvo, Archibald, & Murray, 1994; Mathiowetz, 2003). 
This questionnaire asks participants to recall fatigue levels over the last four weeks. 
One important consideration of this measure in fatigue research is that it is not 
specific to cognitive fatigue. This is problematic because levels of cognitive fatigue 
can be experienced independently from levels of physical fatigue (Benedict et al., 
2002; DeLuca, 2005). The Modified Fatigue Impact Scale (MFIS) addresses this 
problem by specifically examining various subtypes of fatigue, one of these being 
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cognitive fatigue (Ritvo et al., 1997). The MFIS has been employed to assess trait 
cognitive fatigue in pwMS (Tellez et al., 2005). However, measuring trait fatigue 
does not always align with the way that cognitive fatigue is objectively examined 
(i.e., assessing changes across a single session; Morrow et al., 2009). Therefore, 
claims into the relationships between subjective and objective fatigue are 
questionable.  
 Given the discrepancies between the temporal nature of the objective 
measurements, and the stable subjective measure (trait fatigue measures), it is 
unsurprising that negligible correlations have been discovered (Morrow et al., 2009). 
Trait measures may lack the sensitivity to assess changing fatigue across time. In 
order to assess the relationship between objective and subjective cognitive fatigue in 
a single session it would be practical to ask questions that relate to how the 
individuals are currently feeling (i.e., online awareness). This can be achieved by 
measuring state fatigue. 
State fatigue.  
 Levels of state fatigue can be inferred through individuals ‘online’ self-
reports. Given state fatigue allows for an ‘online’ assessment, it may have a stronger 
relationship with actual cognitive fatigue, in a similar manner to studies that have 
examined ‘online’ awareness of cognitive abilities (Goverover et al., 2014). Indeed, 
recent research has demonstrated that online measures, may be more sensitive to 
overly fatiguing tasks, in comparison to self-reported intellectual measures of fatigue 
(Genova et al., 2013). However, the extent to which these self-report measures are 
related to actual declines in objective performance remains unclear and requires 
further examination (Krupp & Elkins, 2000; Sandry et al., 2014). Examination of the 
extent pwMS evaluate declining cognitive performance (i.e., objectively assessed 
COGNITIVE FATIGUE IN MULTIPLE SCLEROSIS 
 
 
15 
cognitive fatigue) is important in order to gain an understanding of the nature of 
cognitive fatigue as it is appraised by pwMS.  
 Online awareness of cognitive fatigue is often obtained through use of a 
Visual Analogue Scale (VAS). In these scales, individuals are required to indicate 
how they feel on a scale of two extremes, ‘not at all fatigued’ to ‘extremely fatigued’. 
A prevailing issue in the MS literature has been the use of a single question to assess 
an individual’s online level of fatigue (Krupp & Elkins, 2000; Sandry et al., 2014). 
This limitation may be addressed through the use of the VAS to evaluate fatigue 
severity (VAS-F; Lee, Hicks, & Nino-Murcia, 1991). The VAS-F has 18 items where 
individuals rate their current levels of fatigue (and energy), thus it provides a more 
comprehensive account of the individual’s experience. To date, however, there have 
been no studies to employ the VAS-F to assess ‘online’ reports of cognitive fatigue 
in relation to declining cognitive performance over time. 
Objectively measuring fatigue  
 The objective assessment of cognitive fatigue has proven to be a challenging 
task (Sandry et al., 2014). Largely owing to this is the fact that fatigue is most 
commonly conceptualised as an experience or feeling that a person has about their 
levels of ‘tiredness’. Nonetheless, several hypotheses have been proposed in the 
literature in an attempt to explain the mechanisms underlying the experience of 
cognitive fatigue in MS.  
 One proposed explanation of the experience cognitive fatigue is the cognitive 
domain hypothesis (Sandry et al., 2014). This hypothesis proposes that pwMS are 
more prone to deficits within particular cognitive domains (e.g., speed of processing 
and working memory, as opposed to knowledge of words; Benedict et al., 2002). As 
a consequence, when tasks require them to utilise these affected domains, psMS will 
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experience fatigue, as a result of expending more resources (Sandry et al., 2014). 
Whilst this hypothesis has good theoretical justifications, to date, there is a lack of 
empirical support for this.  
 Another proposed hypothesis is the cognitive load hypothesis. This theory 
suggests that cognitively demanding tasks are more likely to result in fatigue (Sandry 
et al., 2014). However, empirical support for this theory is also lacking. One study 
that has attempted to examine this in pwMS was conducted by Bailey, Channon, and 
Beaumont (2007), where the n-back task was employed, and manipulated to increase 
the level of cognitive load (i.e., 0-back to one 1-back task). Both the 0-back and 1-
back tasks were administered twice to see changes across the individual test and 
across repeated administration. Findings suggested, irrespective of cognitive load, 
performance decreased temporally. In the 0-back, decreases in performance were 
observed across the single administration, whereas, in the 1-back, decreases in 
performance were not observed until the second administration. As Bailey et al. did 
not directly compare performance between the 0-back and 1-back tasks claims 
relating to fatigue due to cognitive load are questionable. Given that decreased 
performance was present across both the ‘low’ and ‘high’ load. The findings may 
more accurately align with the temporal hypothesis.  
 The temporal hypothesis suggests that fatigue is secondary to cognitive 
impairments, and in particular, slowed processing speed and attentional impairments 
(Andreasen, Spliid, Andersen, & Jakobsen, 2010). The basic premise is that as a 
result of these impairments, individuals need to employ more neural resources than 
healthy individuals to complete the same tasks (Andreasen et al., 2010). This can 
lead to decreased performance on tasks that require sustained mental effort (Sandry 
et al., 2014). Initial support for the temporal hypothesis can be observed by a study 
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conducted by Krupp and Elkins (2000) who measured declining performance over 
time by repeating tests in the same testing session. It was found that, whereas 
performance of control participants improved across the testing session, pwMS 
declined. More recently, Sandry et al. (2014) simultaneously examined the three 
fatigue hypotheses (cognitive domain, cognitive load and temporal hypothesis) and 
found the greatest support for the temporal fatigue hypothesis. They found, 
consistent with Bailey et al. (2007), cognitive fatigue increased as a result of 
sustained mental effort to the task (i.e., performance was poorer during later runs), 
regardless of cognitive load. Importantly, these three studies provided justification 
that performance over time may be a plausible means of quantifying the experience 
of fatigue in pwMS.  
 These studies have predominantly relied on standard neuropsychological test 
batteries. However, given that the temporal hypothesis proposes that fatigue is a 
secondary result of slowed processing speed and attentional impairments; measures 
confounded by other factors (e.g., cognitive load, or cognitive domain) may impact 
the validity of assessing this hypothesis. Potentially a more appropriate way to assess 
the temporal hypothesis may be through a measure of sustained attention. Therefore, 
given the inconsistencies of studies that have implemented standard 
neuropsychological tests, the current study employed the Conners Continuous 
Performance Test - 3 (CPT-3). This includes a measure of sustained attention. It is 
proposed that, should the temporal hypothesis hold true, the CPT-3 will detect 
changes in accuracy and response time across both a single administrations and 
across repeated testing in the same session.  
The Relationship Between the Temporal Hypothesis and Subjective Fatigue.  
 The three studies mentioned above (Bailey et al., 2007; Krupp & Elkins, 
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2000; Sandry et al. 2014) also attempt to assess the relationship between objective 
and subjective cognitive fatigue. All studies found non-significant correlations 
between deteriorating performance and ‘online’ assessments of fatigue. However, all 
studies shared the same limitation preventing confidence in interpretation of their 
conclusions; only a single item was used to assess subjective fatigue. Furthering this, 
the question Bailey et al. (2007) employed was not specific to cognitive fatigue. Of 
these studies both Krupp and Elkins (2000), and Bailey et al. attained a measure of 
intellectual assessment; the Fatigue Severity Scale (Krupp et al., 1989), which also 
was uncorrelated objective performance. Whilst these studies attempted to assess the 
relationship between subjective and objective measures, this was in respect to 
correlational relationships. Specifically, it was not of the interest of these papers to 
examine awareness of fatigue (i.e., the alignment between the subjective reports and 
objective performance). Therefore, awareness of cognitive fatigue remains an area of 
research that is yet to be examined.  
Aims and Hypotheses  
 The current study aimed to further examine the relationship between the 
subjective experience of cognitive fatigue and objectively measured cognitive fatigue 
by improving on the methodological flaws of past research (Krupp & Elkins, 2000; 
Sandry et al., 2014). This will be achieved by employing reliable and valid methods 
of assessing both state and trait self-reported cognitive fatigue to predict 
performance on an objective test of sustained attention (CPT-3) that is administered 
twice in the same testing session. Finally, the current study aims to explore 
awareness into fatigue by examining match between both self-reported trait and state 
cognitive fatigue and objectively measured cognitive fatigue. The aims of the current 
study will allow for a more thorough examination of the nature of fatigue and how 
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this may be experienced in pwMS.  
 In line with prior research demonstrating cognitive impairments in pwMS 
(Bagert, Camplair, & Bourdette, 2002; Brassington & Marsh, 1998), it was 
hypothesised that pwMS would have poorer scores on the neuropsychological tests, 
compared to the demographically matched healthy control participants (HC). 
Secondly, based on high prevalence rates of cognitive fatigue in pwMS (Krupp, 
LaRocca, Muir-Nash, & Steinberg, 1989), it was hypothesised that pwMS would 
have higher self-reported scores on the MFIS and VAS-F in comparison to the HC 
sample. Further, consistent with the findings of Krupp and Elkins (2000), it was 
hypothesised that pwMS, but not HC participants, will demonstrate decreased 
performance on the sustained attention measures on the second administration of the 
CPT-3, in comparison to the first administration (i.e., there will be a significant 
interaction). It was also hypothesised that ‘online’ assessment of cognitive fatigue 
(state fatigue) rather than ‘intellectual’ assessment of cognitive fatigue (trait fatigue) 
will be predictive of objective cognitive fatigue. Hence providing support for the 
notion that intellectual and online awareness of fatigue are indeed separate constructs 
that need to be examined more thoroughly in future research. Finally, based on the 
work of Goverover et al. (2014) who found that awareness of cognitive abilities were 
only impaired (i.e., overestimations of impairment) for pwMS in respect to their 
intellectual, but not online self-assessments, it was hypothesised that levels of 
intellectual awareness of fatigue, but not online awareness of fatigue, will differ 
between pwMS and HC.   
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Method 
Participants  
 Participants included 31 pwMS and 30 HC (for demographic data see Table 
1). The average disease duration for pwMS was 11 years (SD = 8 years), the disease 
characteristics of which are presented in Table 2. A higher ratio of females was 
attained, as this is reflective of higher prevalence of MS amongst females (Harbo et 
al., 2013). Overall, the proportion of females to males did not differ between the 
groups (χ2 = .26, p = .613). An a priori power analysis conducted using G*Power 
(version 3.1.9.2; Faul, Erdfelder, Lang, & Buchner, 2007) indicated that a sample 
size of 46 participants would be required in order to obtain a large effect size for 
deteriorating test performance across time (d =.75, alpha level = .05, power =.80; 
based on the results from Krupp and Elkins, 2000). 
  The MS participants were primarily recruited by direct invitation through a 
letter sent to participants of the Australian Multiple Sclerosis Longitudinal Study 
(AMSLS) managed by the Menzies Institute of Medical Research (Appendix B). 
Additionally, participants were recruited by referral through the MS Society of 
Tasmania, local MS neurologists and health professionals, and advertisements placed 
on the MS Society of Tasmania Facebook page. HC participants were recruited 
through advertising on the University of Tasmania’s Newnham Campus noticeboards 
and advertisement on personal Facebook pages (advisement material shown in 
Appendix C). 
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Table 1  
Participant Demographic Characteristics  
 MS  HC    
Demographics M (SD)  M (SD) t (59) p Cohens d 
Female  22 (37%)  23 (36%)    
Male  9 (14%)  7 (11%)    
Age  47.77 (12.19)  44.37 (11.37) -1.13 .264 .29 
Education  12.13 (1.57)  12.87 (1.91) 1.65 .105 .42 
Intelligence 102.87 (5.27)  104.38 (5.27) 1.16 .252 .29 
Anxiety 7.42 (4.33)  5.87 (2.94) -1.64# .108# .42 
Depression  6.10 (3.36)  3.10 (3.16) -3.59 .001 .92 
Note. Frequency values for gender are shown and parenthesis indicate percentages of 
the overall sample; An estimation of premorbid intelligence was calculated based on 
the formula developed by Barona, Reynolds, and Chastain (1984); #Equal variance 
not assumed statistic reported; Additional analyses revealed the significant difference 
in depression did not account for between group difference observed in other 
analyses (see Appendix D for analyses). 
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Table 2  
Participant Disease Characteristics  
Type of MS n 
Relapsing Remitting 22 (73%) 
Secondary Progressive 2 (7%) 
Primary Progressive  5 (17%) 
Relapsing Progressive   1 (3%) 
 Note. MS-type is self-reported. Percentages of MS sample are shown in brackets.  
  
 Participants were excluded from the study if any of the following were 
present: (1) not aged between 18 and 65 years; (2) a diagnosis of a psychotic, bipolar 
or related disorder; (3) a history of brain injury or other neurological illness (e.g., 
stroke, epilepsy); (4) a history of alcohol or illicit drug abuse; (5) unable to speak and 
read English fluently; (6) uncorrected visual difficulties; and (7) were pregnant. 
Additional exclusion criterion for pwMS was a disease relapse (symptom flare-up) 
within the two weeks preceding assessment. For pwMS, a diagnosis of clinically 
definite MS as defined by the McDonald criteria (Polman et al., 2011) was required.  
Design  
 The study employed a cross-sectional design to examine the relationship 
between objective and subjective measures of cognitive fatigue in pwMS. 
Additionally a within-subjects design to examine changing self-reported cognitive 
fatigue and cognitive performance over the course of a testing session was utilised.  
Materials   
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Self- Report Questionnaires.  
 Demographic questions. Demographic questions relating to individuals’ age, 
gender, and years of education were completed in a self-report survey. 
 Hospital Anxiety and Depression Scale (HADS). The HADS (Zigmond & 
Snaith, 1983) is a 14-item questionnaire that assesses current levels of depression 
and anxiety, with 7-items forming both a depression and an anxiety subscale. 
Participants are required to respond to each item (e.g., ‘I feel tense or ‘wound up”) 
on a 4-point scale: 0 (little symptom occurrence) to 3 (higher symptom occurrence). 
Subscale scores range from 0–21, with higher scores indicative of higher 
symptomology. Severity levels are specified by the following: normal (0–7), mild 
(8–10), moderate (11–14) or severe (15–21). The scale avoids reliance on 
symptomatic aspects of depression and anxiety that may also be common with the 
neurovegetative symptoms of MS (e.g., fatigue). The HADS has high levels of 
internal consistency for the depression and anxiety subscales (Cronbach's α=.94 and 
.92, respectively; Honarmand & Feinstein, 2009), and high test-retest reliability over 
a 3-week period (r = .91; Spinhoven et al., 1997). The HADS was utilised in as prior 
research indicates a relationship between depression and fatigue (Bakshi et al., 
2000). 
 Modified Fatigue Impact Scale (MFIS). The MFIS was developed for 
clinicians and researchers and forms part of the MS Quality of Life Survey (Ritvo et 
al., 1997). The 21-item scale comprises of three subscales: physical, cognitive and 
psychosocial. Items are rated using a Likert type scale, with response options ranging 
from 0 (never) to 4 (almost always), higher scores indicating more severe fatigue. 
For the purpose of the study, the cognitive subscale items were used (10 items; score 
range = 0-40). The MFIS has excellent internal consistency (Cronbach’s α = .93; 
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Ritvo et al., 1997), and good test-rest reliability over a 6-month period (r = .86; 
Learmonth et al., 2013). 
 Visual Analogue Scale – Fatigue (VAS-F). The VAS-F (Lee, Hicks, & 
Nino-Murcia, 199) is an 18-item self-report scale, which asks participants to rate 
their current levels of fatigue (13-items) and energy (5-items) between two extreme 
indictors of occurrence (e.g., ‘Not at all tired’ to ‘Extremely tired’). The scale has 
excellent internal consistency in both healthy individuals and individuals with 
sleeping disorders (Cronbach’s α above .91), and demonstrates good discrimination 
from self-reported measures of mood (Lee et al., 1991). Energy items are reversed, 
giving an overall fatigue score.  
Neuropsychological Tests.  
 The Brief Repeatable Neuropsychological Battery (BRNB; Rao, 1990), 
specifically developed to assess cognitive functioning in MS was administered. This 
battery comprises of the tests mentioned below. Forms A and B of the tests were 
implemented.  
 Selective Reminding Test (SRT). The SRT (Buschke, 1973) was employed to 
assess unstructured verbal learning and memory. A list of 12 unrelated words are 
read to participants, who are then asked to recall the words in any sequence. The 
participants are then read the words they missed, and again asked to recall the entire 
list. There are a total of five learning trials. Following a 15 to 25-minute delay, 
participants are asked to recall the list again. The SRT has been found to have good 
internal consistency (Cronbach’s α above .85; Grober, Ocepek-Welikson, & Teresi, 
2009), and has previously been validated for use in MS populations (Beatty et al., 
1996). The SRT assesses both short (the total number of words recalled across the six 
learning trials) and long-term memory (total delayed recall).   
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 10/36 Spatial Recognition Test (SPART). The SPART (Rao, 1990) is a test 
of visuospatial learning and memory. Participants view a 6×6 (25×25cm) grid with 
10 black circles in specific locations for 10 seconds. The marked grid is then 
replaced with a blank grid and participants are required to replicate the pattern. The 
test is completed three times using the same pattern. Following 15 to 25-minute 
delay, the participant is asked to recreate the pattern again, this assess LTM. Test-
retest reliability is high for the immediate recall task, however is only adequate for 
the delayed recall (ICC r = .85 and .57, respectively; as measured on three occasions 
over 18-months; Portaccio et al., 2010) Scores are calculated based on the correct 
responses across the three learning trials, and the delayed total.  
 Paced Serial Addition Test (PASAT). The PASAT (Gornwall, 1977) assesses 
working memory, divided attention, and information processing speed. Single digit 
numbers are presented to the participant via voice recording. Participants are 
instructed to provide verbal responses of the sum of two consecutive digits for the 
entire sequence of digits. The test involves two trials, each with 60 numbers; the first 
trail has 3-second intervals between digits and the second trial has 2-second intervals. 
The PASAT has high internal consistency (Cronbach’s α above .91; Crawford, 
Obonsawin & Allan, 1998) and high test-retest reliability over a three-month period 
(Spearman’s correlation = .80; Sjøgren, Thomsen & Olsen, 2000). Scores are based 
on the correct number of responses across the two trials.  
 Symbol Digits Modality Test (SDMT). The SDMT (Smith, 1982) assesses 
sustained attention, visual scanning and tracking. Using a reference key comprising 
of nine geometric symbols labeled from 1 to 9, the examinee has 90 seconds to 
verbally pair a number with the corresponding symbol. The SDMT, has high 
concurrent validity with the Digit Symbol subtest of the WAIS (r = .75-.85; Morgan 
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& Wheelock, 1992), and has high test-retest over a one-month period (Spearman 
correlation = .80; Benedict et al., 2008). Scores on this test are the total number of 
correct number-symbol pairs.  
 Verbal Fluency Task. The Verbal Fluency task (Rao, 1990) assesses verbal 
generation ability. Participants are asked to generate as many words as possible 
starting with a particular letter of the alphabet in 60 seconds. The participants 
complete three letter trials (Form A = F, O, J; Form B = A, N, V). Participants are 
instructed not to use the same word with different endings (e.g., sip, sipped, sipping), 
numbers (e.g., seventy, seventy one), or words that ordinarily begin with a capital 
letter (e.g., names of places and people). Parallel versions of this test demonstrate 
very good internal consistency in mixed clinical samples (Strauss, Sherman, & 
Spreen, 2006). The verbal fluency task has high test-retest reliability over an 18-
month period (ICC = .85; Portaccio et al., 2010). Scores are calculated on the total 
number of correct words across the three letter trails.  
Additional neuropsychological tests administered to accompany the BRNB 
include the following.  
 Weschler Memory Scale 4th Edition: Logical Memory I and II (WMS-IV 
LMI and LMII). The LM tasks (Wechsler & Drozdick, 2009) assesse structured 
verbal memory. Short stories are presented orally to participants, who are required to 
immediately recall the story. Following a period of approximately 20 minutes, 
participants are asked to recall the story. The LM tasks forms part of the Wechsler 
Memory Scale, which has been found to have excellent internal consistency (r =.83-
.97) and high test-retest reliability over 14-84 days (r = .81; The British 
Psychological Society, 2012). Scores are calculated based on the number of correct 
details recalled for the immediate trail, and for delayed trial.  
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 Conners Continuous Performance Test – 3 (CPT–3). The CPT-3 (Conners, 
2014) is a computerised task to assess attention difficulties. This test was used in the 
current study to measure objective cognitive fatigue. Indices in the test include 
measures of inattentiveness, vigilance, and sustained attention. Measures of 
inattentiveness (commission and omission errors) and sustained attention will 
specifically be used in this study. The task requires participants to press the space bar 
every time they see a letter on the computer screen, except the letter “X”, where they 
are asked to not provide a response and wait for the next letter to appear. Time 
intervals between letter presentations vary (1, 2 and 4 seconds) throughout the 14-
minute test. The task is a valid tool, not for only ADHD populations, but also 
assessing attention deficits that may be secondary to other disorders (Conners, 2014). 
The CPT-3 has good test-retest reliability following a one-week delay (.70-.90 for 
the various indices; Conners, 2014). Sustained attention is a combination of the rates 
of omissions (measured by missed targets), commissions (measured by responding to 
a non-target) as well as hit reaction time (HRT; measured by changes in reaction 
across time) across the 14-minute trial. The CPT-3 produces t-scores for the three 
above indices with higher scores being indicative of poorer performance.  
Procedure 
 Prospective participants contacted the researchers to complete a screening 
interview (Appendix E), which ensured eligibility and to arrange a mutual time to 
complete testing, at either the University of Tasmania Newnham or Burnie Campus. 
Eligible participants were sent a package containing a letter confirming testing 
details, an information sheet, and consent form (Appendix F). A hard copy of the 
survey was sent to participants or made available online through SurveyMonkey. 
Participants were asked to complete the survey 1-7 days prior to their assessment. 
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The day prior to testing, participants were phoned to confirm their attendance. At this 
time, disease relapse status of the participants was checked according to the 
guidelines of Brown et al. (2006; Appendix G). A relapse in the past 2 weeks 
resulted in rescheduling of the testing session. Prior to giving informed consent the 
details of the study were verbally discussed and participants were required to read the 
information sheet to ensure they understood the requirements of the study. All 
participants were advised, both at screening and at interview, that they were free to 
withdraw from the study at any stage without consequence. 
 Participants were tested in the morning to control for time of day effects 
associated with fatigue. A brief interview was conducted immediately prior to testing 
to obtain basic details relevant to disease status and medical history (Appendix H). 
Additional information was obtained regarding age and date of disease onset, type of 
MS. The testing session took between 92 and 178 minutes to complete. Test order 
and test forms were counterbalanced across participants to minimise any possible 
order effects, this resulted in four test batteries (Table 3 contains test battery A and 
B, battery C and D are presented in Appendix I). Important for the present study, was 
the administration of the CPT-3 test, which at Time 1 occurred on average 35 
minutes (SD = 5-minutes) into the testing session and Time 2 occurred on average at 
113 minutes (SD = 17-minutes). Also important was the administration of the VAS-F 
at Baseline (prior to the administration of the first neuropsychological test), Time 1 
(immediately post CPT-3 Time 1), and Time 2 (immediately post CPT-3 Time 2). 
Tests were administered in accordance with the manual’s standardised instructions. 
All participants who partook in the study received $60 remuneration for their time.  
Estimation of missing scores. Five pwMS were unable to complete the 2-sec 
trial of the PASAT (i.e., they were significantly impaired on the task). Where this 
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occurred, scores were estimated based on z-score performance of the 3-sec trial of 
the task. Specifically, z-scores were calculated for the HC data for the 3 and 2 second 
trial. Using this normative data, z-scores were then calculated for impaired 
participants’ 3-sec trial performance. This z-score was then used to estimate 
performance on the 2-sec trial using the normative information (i.e., the z-score was 
substituted into the formula: M – (z-score × SD)).  
 Cognitive Impairment Status. Additional analyses were conducted to 
examine if subjective fatigue was dependent on cognitive impairment. Cognitive 
impairment was determined according to ninth percentile cut-off scores, based on the 
normative data obtained from the HC. Individuals were classified as being impaired 
if they scored below the ninth percentile on two or more tests. This resulted in 17 
pwMS being classified as cognitively impaired. 
Calculating discrepancy scores. An estimation of intellectual and online 
awareness was obtained by calculating discrepancy scores between the self-report 
and objective fatigue measures (i.e., CPT-3 indices). This was achieved by 
transforming raw scores for the subjective measures (MFIS and VAS-F) and 
objective fatigue (CPT-3 HRT and commission) measures to z-scores (based on the 
overall sample). When analysing objective fatigue in relation to trait subjective 
fatigue (to assess intellectual awareness), the second administration of the CPT-3 
was used. This was because the second administration of the CPT-3 was most likely 
to be indicative of a state of fatigue and would better resemble the fatigue that may 
be induced by undertaking everyday activities. Discrepancy scores were calculated 
by subtracting the z-scores of self-reported fatigue measures away from the CPT-3 z-
scores (e.g., Time 1 CPT-3 HRT z-score minus Time 1 VAS-F z-score). Negative 
scores represent over-estimation of self-reported fatigue relative to objectively 
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measured performance, whereas positive scores represent an under-estimation of 
self-reported fatigue.  
Statistical Analysis  
 Data were analysed using SPSS version 23. Alpha levels were maintained at 
.05 for all analyses to determine significant effects. Effect sizes for analyses were 
calculated and interpreted in accordance to Cohen’s recommendations (Cohen, 
1992). Specifically, for Cohen’s d .20 indicates a small effect, .50 a moderate effect 
and .80 a large effect. Partial eta-squared (η2) values were interpreted for omnibus 
tests of significance, where .01 was representative of a small effect, .09 a medium 
effect and .25 a large effect. Correlations were interpreted as .1 is a small effect, .3 is 
a medium effect and .5 is a large effect. Additionally, the magnitude of the regression 
analyses (R2) were interpreted by the recommendation Ferguson (2009), whereby, 
.04 as a minimum interpretable effect, .25 as a moderate effect and .64 as a strong 
effect. For the Mann-Whitney U analysis the effect size was calculated in accordance 
with the recommendations of Fritz, Morris, and Richler (2012) using the formula: r = 
z/√𝑁 (r-values interpreted in accordance with Cohen, 1992).  
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Table 3 
Neuropsychological Tests Version A and B.  
Test Battery Approximate Time (min) 
1. Visual Analogue Scale - Fatigue 3-5 
2. Selective Reminding Test  8-10 
3. Logical Memory Test  3-5 
4. 10/36 Spatial Recognition Test  5-7 
5. Symbol Digits Modality Test  3 
6. Paced Serial Addition Test  10-12 
7. Selective Reminding Test – Delayed Recall Trial  1-2 
8. Logical Memory Test – Delayed Recall Trial   1-2 
9. 10/36 Spatial Recognition Test – Delayed Recall Trial  1-2 
10. Verbal Fluency task  4-5 
11. Conners Continuous Performance Test – 3 (CPT-3) 16 
12. Visual Analogue Scale - Fatigue 2-3 
13. The Awareness of Social Inference Test - Short (TASIT-S)* 25-30 
SHORT BREAK (5-10 MINS)  
14. Selective Reminding Test 8-10 
15. Logical Memory Test  3-5 
16. 10/36 Spatial Recognition Test 5-7 
17. Symbol Digits Modality Test 3 
18. Paced Serial Addition Test  10-12 
19. Selective Reminding Test – Delayed Recall Trial  1-2 
20. Logical Memory Test – Delayed Recall Trial   1-2 
21. 10/36 Spatial Recognition Test – Delated Recall Trial 1-2 
22. Verbal Fluency Task  3 
23. Conners Continuous Performance Test – 3 14 
24. Visual Analogue Scale - Fatigue 2-3 
Note. Form A was utilised for the first half of the testing in version A and Form B 
first for version B. *The Awareness of Social Inference Test – Short (TASIT-S) and 
the second half of the test battery will be published in separate papers.  
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Data Screening  
 Prior to analyses being conducted, data screening was performed. Several 
variables were detected as having a moderate positive skew (verbal fluency, the 
CPT-3; HRT administration two, and omissions administration one and two), based 
on a calculated normed skewness statistic greater than 3.29 (Tabachnick & Fidell, 
2013). All variables were square root transformed which normalised the distribution 
of the variables and reduced the frequencies of outliers. Analyses were then 
conducted using both the raw data and the transformed data. Given that the use of 
transformed data had no impact on the results (Appendix J), for ease of 
interpretation, all results presented in this paper are bases on the raw data (Appendix 
K).  
 The current study employed a range of statistical methods to interpret the 
results. A series of independent t-tests were conducted to examine the differences 
between pwMS and the HC on: demographic data, age, education, estimated full 
scale intelligence, anxiety and depression. Additional Analyses were conducted to 
determine if depression was significantly altering the findings between-group 
findings., the first administration of the neuropsychological tests, and MFIS scores. 
 Mixed factorial ANOVAs with group as the between subject’s variables were 
conducted to examine changes in the VAS, and changes across the three measures of 
the CPT-3 (HRT, commissions, omissions). As omissions did not differ between 
groups, the remainder of the analysis only examined HRT and commissions. 
ANOVAs were followed up with both independent sample t-tests and paired samples 
t-tests.  Independent samples t-tests were also conducted to detect between group 
differences on insight scores. However, due to a violation of homogeneity of 
variance in the independent samples t-test examining insight based on HRT Time 2 
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and VAS-F Time 2 scores, a Mann-Whitney U non-parametric analysis was 
conducted. Finally, four regression analyses were conducted to examine ability of 
both state (VAS-2 or VAS-3) and trait (MFIS) subjective fatigue measures to predict 
performance on the objective measures of fatigue (HRT and commissions).  
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Results 
Baseline Neuropsychological tests 
 The results from the first administration of the neuropsychological tests 
revealed that pwMS were significantly impaired on a range of tests (SRT, LM, SDM, 
PASAT, and both SRT and LM delayed), in comparison to the HC. Table 4 provides 
an overview of test performance for each group.  
Objective Cognitive Fatigue 
 Hit Response Time (HRT). The results from the 2 (group) × 2 (time) mixed 
factorial ANOVA demonstrated no main effect for group on HRT, F(1, 59) = 1.80, p 
= .185, η2 =.03. That is, overall performance between and pwMS (M = 53.08, SD = 
7.84) and HC (M = 50.38, SD = 7.85) did not differ. There was also no significant 
main effect of time, F(1, 59) = .00, p = .982, η2 =.00, with HRT at Time 1 (M = 
51.75, SD = 9.11) being equivalent to HRT at Time 2 (M = 51.72, SD = 10.26). 
However, there was a significant interaction between group and time, F(1, 59) = 
7.50, p = .008, η2 = .18 (see Figure 5). Post-hoc examinations were conducted using 
independent samples t-tests and paired samples t-tests. Specifically, independent 
samples t-tests revealed that there was no difference at Time 1, t(59) = .56, p = .578, 
d = .14. However, at Time 2, pwMS performed significantly poorer than HC, t(59) = 
-2.55, p = .013, d = .14. In addition, paired samples t-tests indicated there was not a 
significant change in performance for pwMS across time, t(30) = -1.63, p = .115, d = 
.40. However, HC performance significantly improved across time t(29) = 2.57, p = 
.015, d = .43.
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Table 4  
Mean scores on the neuropsychological tests.  
Note. CI = confidence interval; LL = lower limit; UL = upper limit. 
 
MS   HC      
  
 
 
Test 
 
M (SD) 
95% CI     
M (SD) 
95% CI      
LL UL   LL UL t p Cohens d 
SRT - Total Recall 46.32 (12.01) 41.92 50.73   52.43 (8.98) 49.08 55.79 2.24 .028 .58 
LM 10.26 (3.16) 9.10 11.42   12.86 (3.71) 11.48 14.25 2.96 .004 .82 
10/36 - Total 19.94 (4.80) 18.18 21.69   21.30 (5.80) 19.13 23.47 1.00 .320 .26 
SDM 47.39 (9.94) 43.73 51.03   59.17 (10.80) 55.14 63.20 4.44 <.001 1.14 
PASAT 74.10 (22.54) 65.83 82.36   85.17 (17.03) 78.80 91.52 2.16 .035 .55 
SRT – Delayed 6.74 (2.86) 5.69 7.79   8.70 (2.51) 7.77 9.67 2.84 .006 .73 
LM – Delayed 8.55 (3.34) 7.33 9.77   11.93 (4.03) 10.43 13.44 3.58 .001 .92 
10/36 Test – Delayed 7.10 (2.15) 6.31 7.89   7.40 (2.03) 6.64 8.16 .57 .573 .14 
Verbal Fluency 28.10 (10.35) 24.92 32.50   32.53 (11.11) 28.39 36.82 1.39 .169 .41 
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Figure 5. Interaction between group and hit response time across time session on the 
CPT-3 task. Higher t-scores represent poorer performance. Error bars represent 
standard errors. 
 
 Commissions. The results from the 2 (group) × 2 (time) mixed factorial 
ANOVA demonstrated pwMS (M = 53.77, SD = 8.36) had more commission errors 
than HC (M = 48.58, SD = 8.36), F(1, 59) = 5.88, p = .018, η2=.09. There was also a 
main effect of time, with commission rates being higher at Time 1 (M = 50.60, SD = 
8.36) than Time 2 (M = 51.76, SD = 8.95), F(1, 59) = 4.06, p = .050, η2 = .06. 
Furthermore, there was a significant interaction between group and time, F(1, 59) = 
10.26, p = .002, η2 = .15 (see Figure 6). To further examine this relationship, post-
hoc independent samples t-tests were conducted. While no group differences at Time 
1 were detected [t(59) = -1.55, p = .126, d = .14], the MS participants had 
significantly more commission errors at Time 2 [t(59) = -3.08, p = .003, d = .79]. 
45
47
49
51
53
55
57
59
Time 1 Time 2
t-
sc
o
re
Hit Response Time
MS
Control
COGNITIVE FATIGUE IN MULTIPLE SCLEROSIS 
 
 
37 
Paired samples t-tests indicated that whereas pwMS performance significantly 
decreased [t(30) = 3.66, p = .001, d = .30], HC performance did not change across 
time [t(29) = .85, p = .400, d = .09]. 
 
Figure 6. Interaction between group and commissions across sessions on the CPT-3 
task. Higher t- score values represent poorer performance. Error bars represent 
standard errors.  
 
 Omissions. The 2 (group) × 2 (time) mixed factorial ANOVA indicated that 
there was no main effect of condition, F(1, 59) = .28, p = .599, η2 = .01. That is, 
levels of omissions did not differ between pwMS (M = 48.57, SD = 7.25) and HC (M 
= 47.58, SD = 7.25). Further, omission rates did not differ from Time 1 (M = 47.93, 
SD = 7.33) to Time 2 (M = 48.22, SD = 8.81), F(1, 59) = .10, p = .754, η2 = .00. 
There was also no significant interaction between group and time, F(1, 59) = .04, p = 
.837, η2 = .01 (see Figure 7). 
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Figure 7. Interaction between group and omissions across sessions on the CPT-3 
task. Higher t-score values represent poorer performance. Error bars represent 
standard errors.  
 
Subjective Cognitive Fatigue  
 An independent samples t-test demonstrated pwMS (M = 15.58, SD = 7.32) 
had higher self-reported trait fatigue (assessed using the MFIS) in comparison to HC 
(M = 9.67, SD = 5.09), t(59) = -3.65, p = -3.65, d = .94.  
 A 2 (group) × 3 (time) mixed factorial ANOVA with VAS-F scores as the 
dependent variable, revealed a significant main effect of condition. Specifically, 
pwMS (M = 90.40, SD = 28.82) reported more fatigue than HC (M = 53.08, SD = 
28.81), F(1, 59) = 25.57, p <.001, η2 = .30. There was also a significant main effect 
of time [F(1.18, 93.11) = 63.59, p < .001, η2 = .52], indicating there were differences 
between Baseline (M = 53.43, SD = 31.41) and Time 1 (M = 71.54, SD = 37.84) 
[t(60) = 5.40, p < .001, d = .51]. Time 1 also differed from Time 2 (M = 91.15, SD = 
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42.59), [t(60) = 7.72, p < .001, d = .47].   
 The interaction revealed Mauchly's test of sphericity was violated (χ2(2) = 
18.04, p < .001, ε = .79), therefore, adjusted degrees of freedom were interpreted 
(Greenhouse-Geisser correction). A significant interaction between group and time 
was present F(1.58, 93.11) = 4.80, p = .016, η2 = .08 (Figure 8). Independent samples 
t-tests revealed pwMS had higher self-reported ratings of fatigue than HC, this was 
consistent across Baseline [t(59) = -3.60, p = .001, d = .90], Time 1 [t(59) = -4.61, p 
< .001, d = 1.17],  and Time 2 [t(59) = -5.13, p < .001, d = 1.30]. Furthermore, 
paired samples t-tests indicated VAS-F scores for pwMS and HC increased from 
Baseline to Time 1 [t(30) = 4.82, p < .001, d = .73;  t(29) = 2.81, p = .009, d = .46 
respectively], and from Time 1 to Time 2 [t(30) = 7.54, p < .001, d = .64;  t(29) = 
3.92, p < .001, d = .36, respectively].  
Subjective fatigue predicting objectively measured fatigue 
 Results from the four multiple regressions with the MFIS and VAS-F self-
report measures of fatigue predicting actual performance on the CPT-3 are presented 
in Table 5. The only model found to be significant was the regression for Time 2 
self-report measures predicting CPT-3 commission errors. Within this model, only 
the VAS-F scores were found to significantly predict individual variance (15%) in 
commission errors. A moderate positive zero-order correlation was also found 
between the MFIS and commission errors at Time 2, and a large positive zero-order 
correlation for the VAS-F at Time 2. Moderate positive zero-order correlations were 
found between the two self-report measures and the commission errors at Time 1.  
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Figure 8. Interaction between group and VAS-F ratings. Higher VAS-F values 
represent greater self-reported fatigue. Error bars represent standard errors. 
 
Assessing insight into fatigue using discrepancy scores 
 When examining discrepancy scores it was found that at Time 1 of the CPT-
3, pwMS reported significantly higher levels of fatigue relative to actual performance 
(i.e., over-reporting fatigue), compared to HC (Table 6 presents means and 
inferential statistics). Due to the violation of homogeneity of variance in the HRT-
VAS-F discrepancy score at Time 2, a Mann-Whitney analysis was conducted. The 
results demonstrated a trend towards over-reporting subjective fatigue (relative to 
actual performance on CPT-3 HRT) in pwMS (Mdn = 35.40) relative to HC (Mdn = 
26.74), U = 333.00, p = .057, r = -.24. All other comparisons of insight revealed no 
significant differences between pwMS and HC (p > .05).  
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Table 5 
Regression Analyses Examining the Predictive Ability of Subjective Measures of Fatigue on Objective Fatigue.  
Note. Zero-order correlations were interpreted according to the guidelines of Cohen  (1992). 
* p < .05 
   Dependent Variables 
 HRT  Commissions 
   95% CI    95% CI 
 R2 r β sr2 B LL UL  R2 r β sr2 B      LL     UL 
Time 1 .05        .10       
     VAS-F  -.10 -.17 .02 -.03 -.12 .06   .27 .20 .04 .05 -.05 .14 
     MFIS  .14 .20 .04 .20 -.20 .61   .26 .19 .03 .22 -.24 .68 
Time 2 .06        .23*       
     VAS-F  -.18 -.22 .03 -.07 -.20 .06   .44* .39 .15 .11 .01 .21 
     MFIS  .12 .19 .05 .30 -.33 .94   .29 .19 .03 .27 -.23 .76 
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Cognitive Fatigue Stratified by Cognitive Impairments 
 Additional t-test analyses were conducted to examine whether fatigue in 
pwMS differed due to cognitive impairment status (impaired compared to not 
impaired). Analyses revealed no significant differences between groups on the three 
objective measures of cognitive fatigue (HRT, commissions and omissions), self-
report measures of fatigue, and insight into fatigue (results for these analyses are 
presented in Appendix L).  
 
Table 6 
Comparisons of Levels of Insight Between pwMS and HC. 
Note. Means and standard deviations are of the z-scores; #Indicates a violation of  
homogeneity of variance, therefore significance and effect sizes are not interpreted. 
 
MS    HC  
 
 M (SD) 
 
M (SD) t(59) p Cohens d 
Time 1: CPT-3 – VAS-F 
 
  
  
 
 
 HRT  -.57 (1.36)   .59 (1.21) 3.54 .001 .90 
 Commissions -.31 (1.23)   .32 (1.23) 2.00 .050 .51 
Time 2: CPT-3 – VAS-F 
 
  
  
 
 
 HRT -.23 (1.51)   .24 (.88) 1.50# – – 
 Commissions -.18 (1.04)   .18 (1.09) 1.34 .186 .34 
Time 2: CPT-3 – MFIS  
 
  
  
 
 
 HRT  -.11 (1.43)   .12 (.90) .74 .462 .14 
 Commissions -.06 (1.27)   .06 (.92) .40 .690 .11 
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Discussion 
 One primary aim of this study was to improve on the existing literature by 
furthering current understandings regarding objectively measured cognitive fatigue 
and its relationship with self-reported cognitive fatigue. The first hypothesis, that 
pwMS would demonstrate poorer performance on the neuropsychological tests, 
compared to the control sample, was partially supported. Consistent with previous 
research (Sepulcre et al., 2006), the current study found that pwMS were impaired in 
the following domains of cognition; structured and unstructured verbal memory, 
sustained and divided attention, working memory and processing speed, and long-
term memory. However, there were no observable differences in verbal fluency, or 
visuospatial learning or delayed recall. Chiaravalloti and DeLuca (2008) report that 
impairments in verbal fluency are one of the least common impairments, affecting 
approximately 15 percent of pwMS, however, impairments to visual memory affect 
over 50 percent of pwMS. This may indicate that levels of impairments in the present 
study may be smaller than prior research.  
 The hypothesis that pwMS would have higher self-reported ratings of 
subjective state and trait cognitive fatigue than healthy participants, as indicated by 
scores on the VAS-F and MFIS, was supported. In particular, the current study found 
that pwMS reported significantly higher levels of state fatigue across all 
administrations of the VAS-F. This is consistent with both prior research (Sandry et 
al., 2014) and the notion that fatigue increases in response to particular tasks, or as 
the day progresses (Branas et al., 2000). Furthermore, pwMS also reported higher 
levels of trait fatigue, in comparison to healthy participants. This is indicative of the 
general and persistent experience of cognitive fatigue amongst pwMS (Branas et al., 
2000). 
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 Prior literature states that there is a temporal basis to the experience of 
cognitive fatigue (Sandry et al., 2014). This study aimed to directly test this theory 
by hypothesising that pwMS, but not healthy participants, would perform more 
poorly on repeated assessment of sustained attention (CPT-3), relative to an initial 
assessment within the same testing session. The study found support for the temporal 
hypothesis based on the following: (1) in pwMS there was a more pronounced 
reaction time change (i.e., slowing reaction time across the 14-minute test 
administration) in the second administration of the sustained attention task relative to 
the first administration; (2) There were increased errors of commission in pwMS in 
the second administration of the sustained attention task relative to the first 
administration. These findings are further discussed below. 
 In respect to reaction time, while no significant difference between groups 
were detected on the first administration of the sustained attention task, significant 
difference between the groups were detected on the second administration. 
Specifically, while the performance of healthy participants improved, the 
performance of pwMS did not change. It is notable, that the effect size for this 
change in pwMS was small to medium (d = .40), which was similar to the effect size 
seen in the control participants (d = .43). This suggests that a possible meaningful 
decrease was observed in pwMS, but not detected due to lack of power. The non-
significant relationship may also have been attributable to the larger variation 
observed in pwMS (SD = 12.60), in comparison to HC (SD = 8.60). The results are 
consistent with prior research, demonstrating pwMS experienced a decrease in 
performance, whereas, controls experienced an increase in performance on 
standardised neuropsychological tests administered over the course of a single testing 
session (Krupp & Elkins, 2000).  
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 Similar to the reaction time performance noted above, while there were no 
differences observed between groups commission rates on the first administration, at 
the second administration pwMS had significantly more errors of commission than 
the healthy control participants. Specifically, pwMS had more commissions in the 
second administration relative to the first, whereas, controls performance remained 
consistent. While this finding supports the hypothesis that pwMS will experience 
declines in performance across testing sessions, it does not support the hypothesis 
that control participants will improve across testing. To summarise, however, present 
study supports the notion that pwMS do indeed experience significant declines in 
performance over a single testing session in line with the temporal theory of 
cognitive fatigue. 
 The results from the current study provide partial support for the hypothesis 
that ‘online’ assessment (i.e., using a measure of state fatigue), rather than 
‘intellectual’ assessment (i.e., using a measure of trait fatigue) of cognitive fatigue 
will predict objective cognitive fatigue. Here it was found that the self-reported 
cognitive fatigue predicted 23 percent of the variance in scores on the second 
administration of the sustained attention task. However, this was only in respect to 
errors of commissions. Of the two subjective measures, the ‘online’ assessment 
measure was the only unique predictor. Online assessment also had a large zero-
order correlation with commission errors at this time. While further regression 
modelling with the self-report measures as predictors were not significant, moderate 
positive correlations were detected between the intellectual assessment of fatigue and 
both reaction time and commission errors, and the online assessment of fatigue and 
reaction time, at the second administration. These results provide support for the 
notion that ‘online’ and ‘intellectual’ assessments of fatigue are separate constructs, 
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which should be examined independently. While online assessments of fatigue 
appear to be most advantageous in predicting actual cognitive fatigue, where their 
use is impractical, intellectual assessment may serve as a reasonable alternative.  
 The current study found no group differences in levels of intellectual 
awareness of cognitive fatigue, thus finding no support for the final hypothesis that a 
group difference would exist in intellectual awareness. This result is not consistent 
with the findings of Goverover et al. (2014) who found that intellectual awareness of 
cognitive ability was lower in pwMS than healthy control participants (i.e., pwMS 
had a tendency to over-report fatigue levels relative to controls). Intellectual 
assessment of fatigue requires a participant to reflect on their experience of fatigue 
over the past four weeks, and thus relies on memory to accurately report levels of 
fatigue. The similar levels of insight between pwMS and healthy control participants 
suggest pwMS are well able to remember experiences of fatigue.  
 The current study found mixed results when examining online awareness in 
pwMS. At the first administration of the sustained attention task, online awareness of 
cognitive fatigue differed between pwMS and healthy controls. In particular, whereas 
pwMS tended to overestimate their experience of cognitive fatigue, healthy control 
participants tended to underestimate it. However, following the second 
administration of the task, arguably after a state of cognitive fatigue was present (as 
indicated by increased commission errors and poorer HRT); online awareness did not 
differ significantly between groups. There was, however, a trend towards pwMS 
overestimating their experience cognitive fatigue, as assessed by the discrepancy 
between self-reported state fatigue and reaction time. 
 The results obtained when examining awareness provide support for the use 
of intellectual measures. Intellectual measures may be viewed as having more utility 
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in clinical practice due to the ease of administration. Nonetheless, where possible 
these measures should be supplemented with ‘online’ measures, as they offer greater 
predictive ability. In respect to intellectual measures, previous research has indicated 
that subjective trait measures offer an invaluable source of information into how an 
individual perceives their abilities, and that these perceptions can be more influential 
than actual abilities (Honan et al., 2015). In this respect, perceptions can influence 
the way individuals behave. Therefore, it is important to understand that the 
consideration of only objective, state or trait fatigue does not fully encompass the 
experience of cognitive fatigue in pwMS. Future research should endeavour to 
uncover the extent to which the various measures of cognitive fatigue relate to 
functional outcomes. 
 A final finding of this current study is that cognitive fatigue was not 
influenced by cognitive impairment. That is, individuals who were classified as 
having impairments did not experience significantly more (or less) cognitive fatigue 
than pwMS not classified with impairments. This supports prior literature that claims 
fatigue can be experienced independently from other impediments (Benedict et al., 
2002; DeLuca, 2005).  
 The findings from the current study provide valuable information into 
understanding the nature of the cognitive fatigue that pwMS experience. The 
measures of the sustained attention on the CPT-3 assessed different aspects of 
cognition. It was found that the ‘online’ assessment of cognitive fatigue was 
predictive of commission errors. However, it was also found that reaction time 
increases temporally; however, subjective ratings were not predictive of this. This 
suggests that current subjective measures that assess ‘online’ cognitive fatigue are 
not sensitive to the varying dimensions of cognitive fatigue. Future research may 
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endeavour to identify domains where fatigue is objectively observable and, 
subsequently, develop measures of cognitive fatigue that relate to the various 
domains. However, given cognitive fatigue has demonstrated to be multifaceted it 
may be challenging to develop measures that can encapsulate the full phenomenon.  
Study Limitations 
 The results of the current study should be interpreted in view of the following 
limitations. In the current study, as well as in past research, depression 
symptomology was higher in the MS participants. The current study did not fully 
examine the role that depression may have played in the relationship between 
subjective and objective cognitive fatigue. This was in part due to the fact that 
overall depression levels of pwMS were in the normal range (i.e., below a score of 
7). Nonetheless, alternative analyses with depression included as a covariate did not 
change the present results. However, it remains possible that depressive 
symptomology may mediate the relationship between subjective and objective 
cognitive fatigue for pwMS. This can be examined in a future larger study that has 
more power to detect significant relationships in mediation-type analyses (Fritz & 
MacKinnon, 2007).  
 A further limitation that should be taken into consideration is that the study 
was conducted in winter and employed a restrictive sample from North and North 
West Tasmanian. As it is common for pwMS to be affected by heat (Davis & 
Jacobson, 1971), therefore, the results from this study may have differed if the study 
was conducted in warmer climates or during warmer months.  
Conclusion 
 The majority of pwMS experience and live with cognitive fatigue on a daily 
basis. This study provided the ability to objectively assess cognitive fatigue by 
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examining declining performance across time on a task of sustained attention, the 
CPT-3. Furthermore, increases in subjective reports of cognitive fatigue were also 
examined, both providing support for the temporal hypothesis. The current study 
provides greater insight into the relationship between subjective and objectively 
measured fatigue. Specifically, the employment of the VAS-F and the CPT-3, can be 
viewed as a large improvement in the literature on fatigue, as it was through these 
measures a relationship between the subjective and objective cognitive fatigue was 
uncovered. The study highlights the importance of attaining ‘online’ assessments in 
both clinical and experimental practices. Due to the absence of effective measures for 
assessing subjective cognitive fatigue, it is recommended that both subjective (trait, 
and where possible, state) and objective measures should be taken. The study 
concludes with the recommendation that future research should attempt to develop a 
VAS that can more thoroughly encompass the multifaceted phenomenon of fatigue. 
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Interview for Ms participants  
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Appendix I 
Test Battery C and D 
Test Battery  Estimated Time (min) 
1.       Visual Analogue Scale - Fatigue 3-5 
4.       10/36 Spatial Recognition Test  5-7 
2.       Selective Reminding Test (SRT)  8-10 
3.  Logical Memory I 3 
5.       Verbal Fluency task 4-5 
9.       10/36 Spatial Recognition Test – Delayed Recall Trial 1-2 
6.       Paced Serial Addition Test (PASAT) 10-12 
7.       SRT – Delayed Recall Trial  1-2 
8.  Logical Memory II 1-2 
10.    Symbol Digits Modality Test  3 
11.    Connor’s Continuous Performance Test – III (CPT-3) 16 
12.    Visual Analogue Scale - Fatigue 2-3 
13.     The Awareness of Social Inference Test – Short (TASIT-S) 25-30 
SHORT BREAK (5-10 MINS)   
16.    10/36 Spatial Recognition Test  5-7 
14.    Selective Reminding Test (SRT)  8-10 
15.  Logical Memory I 3 
17.    Verbal Fluency task 4 
21.    10/36 Spatial Recognition Test – Delayed Recall Trial 1-2 
18.    Paced Serial Addition Test (PASAT) 10-12 
19.    SRT – Delayed Recall Trial 1-2 
20.  Logical Memory II 1-2 
22.   Symbol Digits Modality Test  3 
23.   Connor’s Continuous Performance Test – 3  14 
24.   Visual Analogue Scale - Fatigue 2-3 
  
 Note. Form A was utilised for the first half of the testing in version C and Form B 
first for version D. *The Awareness of Social Inference Test – Short (TASIT-S) and 
the second half of the test battery will be published in separate papers.   
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Conners Administration Times
 
 
 
 
Baseline Neuropsychological Test Data 
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Mixed Factorial ANOVA for Hit Response Time 
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Mixed Factorial ANOVA for Commission Rates 
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Mixed Factorial ANOVA for VAS-F 
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MFIS t-test 
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Regression Analysis 
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Insight Data 
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Appendix K 
Analysis Conducted with transformed data 
Mixed Factorial ANOVA for Hit Response Data 
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Mixed Factorial ANOVA for Omissions Data 
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Comparison of Verbal Fluency  
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Raw data stratified by Impairment 
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Mixed Factorial ANOVA for Hit Response Time 
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Insight Analysis  
 
 
